Kenya has announced new measures to strengthen diabetes care and ensure consistent access to essential medicines as part of efforts to address the rising burden of non-communicable diseases.
The announcement was made on Saturday, November 15, 2025, during the national World Diabetes Day event held at the Nairobi West Prisons Grounds, presided over by Principal Secretary for Medical Services, Dr Ouma Oluga.
This year’s theme, “Support Diabetes Well-being at Workplace,” placed emphasis on integrating diabetes prevention and early detection into work environments.
Dr Oluga urged employers to adopt routine health checks, including blood sugar screening, and highlighted ongoing development of workplace wellness policies targeting sedentary lifestyles and poor dietary habits.
A key development is the receipt of a consignment of diabetes medicines valued at USD 7.2 million (about KSh 1 billion).
Distribution is expected to begin within two weeks to ensure uninterrupted supply across all levels of the health system.
How many Kenyans are living with diabetes?
According to Dr Oluga, approximately 800,000 Kenyans living with diabetes are being mapped to align medication delivery with specific treatment needs and prevent stockouts.
The PS also highlighted ongoing healthcare financing reforms under the Social Health Authority (SHA) aimed at reducing out-of-pocket spending and building a sustainable national health system.
He noted that consistent contributions from income earners are central to improving the availability of services for chronic illnesses.
Broader service delivery reforms were outlined, including strengthening emergency care within the first 24 hours, expanding support for community health promoters, and improving chronic disease management.
Increased investment in data and digital systems is also expected to enhance monitoring, planning, and research for diabetes control.
Screening and awareness campaigns have expanded significantly through partnerships with health agencies and county governments, enabling more Kenyans to identify their risk status and seek early treatment.
Dr Oluga reiterated that the ongoing interventions are intended to improve continuity of care, enhance access to essential medicines, and support a more coordinated national response to diabetes.
